Publication | Open Access

Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Aβ in plasma of patients with Alzheimer's disease

Neurodegenerative DiseasesAlzheimer's DiseaseMedicineN-truncated Pyroglutamate AβDegenerative PathologyNeurochemical BiomarkersAutoantibodiesNeuroscienceNeurologyNeurodegenerationBrain PathologyIgm AutoantibodiesNeuroimmunologyProtective Mechanisms